(BPCA) Information Coordinating Center was funded beneath contract HHSN275201700002C (PI
(BPCA) Data Coordinating Center was funded under contract HHSN275201700002C (PI, Ravinder Anand). Y.S.S.W. was supported by means of a University of North Carolina (UNC)/Nuventra Pharmacokinetics/Pharmacodynamics Fellowship. M.C.-W. received help for investigation from the National Institutes of Health (grants 1R01-HD076676-01A1 and 1K24-AI143971),July 2021 Volume 65 Concern 7 e02149-20 aac.asmWu et al.Antimicrobial Agents and Chemotherapythe National Institute of Allergy and Infectious Ailments (grants HHSN272201500006I and HHSN272201300017I), the National Institute of Kid Wellness and Human Improvement (NICHD) (grant HHSN275201000003I), the U.S. Food and Drug Administration (grant 5U18FD006298), and sector for drug improvement in adults and kids. C.P.H. received salary assistance for study from NICHD (grants 1K23HD090239 and R13HD102136), the National Heart Lung and Blood Institute (NHLBI) (grant R61/R33HL147833), as well as the U.S. Food and Drug Administration (grants 1R01-FD006099 [PI, Matthew Laughon] and 5U18-FD006298 [PI, Daniel K. Benjamin, Jr.]), and from the U.S. government for his work in pediatric clinical IL-6 custom synthesis pharmacology (contract HHSN275201800003I [PI, Daniel K. Benjamin, Jr.] beneath the most effective Pharmaceuticals for Children Act), from the nonprofit Burroughs Wellcome Fund, and from other sponsors for drug development in adults and youngsters (dcri/about-us/ conflict-of-interest/). J.G.G. received study help from the National Institute of Basic Healthcare Sciences (NIGMS)-funded T32 plan (award 5T32GM122741), also because the American Foundation for Pharmaceutical Education (AFPE). D.G. received analysis assistance in the NICHD (grants K23HD083465 and R01HD096435). The content material is solely the duty on the authors and does not necessarily represent the official views of the National Institutes of Wellness. Y.S.S.W. and D.G. wrote the manuscript; Y.S.S.W. and D.G. made the research; Y.S.S.W., M.C.-W., C.P.H., J.G.G., J.A., M.C., and D.G. performed the study; Y.S.S.W. and J.G.G. analyzed the data. PTN Steering mGluR3 Storage & Stability Committee Members contain Daniel K. Benjamin, Jr., Christoph Hornik, Kanecia Zimmerman, Phyllis Kennel, and Rose Beci, Duke Clinical Research Institute, Durham, NC; Chi Dang Hornik, Duke University Medical Center, Durham, NC; Gregory L. Kearns, Texas Christian University and UNTHSC College of Medicine, Fort Worth, TX; Matthew Laughon, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ian M. Paul, Penn State College of Medicine, Hershey, PA; Janice Sullivan, University of Louisville, Louisville, KY; Kelly Wade, Children’s Hospital of Philadelphia, Philadelphia, PA; and Paula Delmore, Wichita Healthcare Study and Education Foundation, Wichita, KS. The Eunice Kennedy Shriver National Institute of Kid Wellness and Human Improvement (NICHD) team members incorporate Perdita Taylor-Zapata and June Lee. The Emmes Enterprise, LLC (Data Coordinating Center), team members consist of Ravinder Anand, Gaurav Sharma, Gina Simone, Kim Kaneshige, and Lawrence Taylor. The PTN Publications Committee is chaired by Thomas Green, Ann Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL. The Pediatric Trials Network trimethoprim-sulfamethoxazole POPS study team, principal investigators (PIs), and study coordinators (SCs) are as follows: in the Duke Clinical Research Institute, Tammy Day (clinical research associate [CRA]); at the Universitde Montr l, Julie Autmizguine (PI); at the University of North Carolina at Chapel Hill, Matthew.
